Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis - Related Studies

Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)

This study is currently recruiting participants.

Study NCT00647348. Last updated on April 3, 2008. Information provided by Imperial College London

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Multiple Sclerosis
		Multiple Sclerosis, Chronic Progressive
		Neoplasm Metastasis
		Sclerosis

2	More general conditions related to this trial
		Autoimmune Diseases
		Autoimmune Diseases of the Nervous System
		Demyelinating Autoimmune Diseases, CNS
		Demyelinating Diseases
		Immune System Diseases
		Neoplasms
		Neoplastic Processes
		Nervous System Diseases
		Pathologic Processes

3	Interventions listed in this trial
		Simvastatin
		Placebo

4	More general drug interventions related to this trial
		Anticholesteremic Agents
		Antilipemic Agents
		Antimetabolites
		Enzyme Inhibitors
		Hydroxymethylglutaryl-CoA Reductase Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Therapeutic Uses

5	Sponsors listed in this trial
		Imperial College London